2021
Subcutaneous Ketamine in Depression: A Systematic Review
Cavenaghi V, da Costa L, Lacerda A, Hirata E, Miguel E, Fraguas R. Subcutaneous Ketamine in Depression: A Systematic Review. Frontiers In Psychiatry 2021, 12: 513068. PMID: 34122156, PMCID: PMC8193034, DOI: 10.3389/fpsyt.2021.513068.Peer-Reviewed Original ResearchRobust antidepressant effectsRacemic ketamineSystematic reviewAntidepressant effectsMultiple dosesDose-titration approachRandomized clinical trialsRisk of biasTransitory side effectsInclusion/exclusion criteriaPubMed/MEDLINESystematic literature searchWeb of ScienceSubcutaneous ketamineCochrane riskRemission rateBias toolRetrospective studyBeneficial efficacySC routeClinical trials
2019
Relative Age and Attention-Deficit/Hyperactivity Disorder: Data From Three Epidemiological Cohorts and a Meta-analysis
Caye A, Petresco S, de Barros A, Bressan R, Gadelha A, Gonçalves H, Manfro A, Matijasevich A, Menezes A, Miguel E, Munhoz T, Pan P, Salum G, Santos I, Kieling C, Rohde L. Relative Age and Attention-Deficit/Hyperactivity Disorder: Data From Three Epidemiological Cohorts and a Meta-analysis. Journal Of The American Academy Of Child & Adolescent Psychiatry 2019, 59: 990-997. PMID: 31442562, DOI: 10.1016/j.jaac.2019.07.939.Peer-Reviewed Original ResearchConceptsYounger ageADHD diagnosisMeta-AnalysisADHD symptomsPelotas cohortCommunity-based cohortPopulation-based cohortAttention-deficit/hyperactivity disorderHigh-risk studiesRelative young ageAttention-deficit/hyperactivity disorder (ADHD) symptomsWeb of ScienceHyperactivity disorder symptomsEpidemiology guidelinesEligible recordsRelative riskObservational studyHigh riskPsychiatric disordersEpidemiological cohortCohortSymptomsDiagnosisEffect estimatesHyperactivity disorder